Literature DB >> 20302812

Genetic animal models for schizophrenia: advantages and limitations of genetic manipulation in drosophila, zebrafish, rodents, and primates.

Akira Sawa1.   

Abstract

Schizophrenia is a debilitating mental illness in which major initial risks of the disease during neurodevelopment may disturb postnatal brain maturation, which results in onset after puberty. Family, twin, and adoption studies have suggested an important role for genetic factors in the etiology of schizophrenia. To address the etiology-associated mechanisms and disease course, use of genetic models, that is, manipulation of genetic susceptibility factors, is currently considered to be a powerful tool for biological studies. In this manuscript, advantages and possible limitations in manipulating genetic susceptibility factors for schizophrenia toward modeling the disease are discussed. In addition to mouse models, the potential to use drosophila, zebrafish, and primates is underscored. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20302812     DOI: 10.1016/S0079-6123(09)17901-3

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  4 in total

Review 1.  The role of rodent models in the discovery of new treatments for schizophrenia: updating our strategy.

Authors:  Holly Moore
Journal:  Schizophr Bull       Date:  2010-09-24       Impact factor: 9.306

Review 2.  Unlocking the treasure trove: from genes to schizophrenia biology.

Authors:  Shane E McCarthy; W Richard McCombie; Aiden Corvin
Journal:  Schizophr Bull       Date:  2014-03-27       Impact factor: 9.306

3.  Characterization of the deleted in autism 1 protein family: implications for studying cognitive disorders.

Authors:  Azhari Aziz; Sean P Harrop; Naomi E Bishop
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

Review 4.  Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders.

Authors:  D Schubert; G J M Martens; S M Kolk
Journal:  Mol Psychiatry       Date:  2014-12-02       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.